Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Roger Misasi

Interventional Pain Medicine Pittsburg, KS Doctor of Osteopathy

NPI 1225063845 CMS profile 967610

1606 N Broadway St, Ste 200, Pittsburg, KS 66762

Open in the dashboard

General payments

$2,038

61 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Roger Misasi of Pittsburg, KS is reported in the CMS Open Payments database as having received $2,038 across 61 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 35th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $50 2
2023 General $780 8
2022 General $366 15
2021 General $461 19
2020 General $341 14
2019 General $41 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Roger Misasi
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Roger Misasi were reported at $0. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Roger Misasi Interventional Pain Medicine median Middle half National median
2019 $41 $684 $216–$2,079 $163
2020 $341 $382 $122–$1,109 $114
2021 $461 $552 $167–$1,554 $132
2022 $366 $605 $187–$1,924 $149
2023 $780 $671 $195–$1,915 $160
2024 $50 $684 $206–$1,837 $164
2025 $0 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Abbott Laboratories $863 35 payments
  2. Pacira Pharmaceuticals Incorporated $724 6 payments
  3. Nevro Corp. $140 1 payment
  4. Baudax Bio Inc. $67 4 payments
  5. AbbVie, Inc. $56 3 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $29 2 payments
  7. Collegium Pharmaceutical, Inc. $26 2 payments
  8. Averitas Pharma Inc. $25 1 payment
  9. Biodelivery Sciences International, Inc. $25 2 payments
  10. Biohaven Pharmaceutical Holding Company Ltd. $21 1 payment
  11. Other $61 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,420 59 payments
  2. Travel and Lodging $618 2 payments
Products named General payments · program years 2019–2024
  1. Iovera $694 5 payments
  2. Proclaim IPG $311 10 payments
  3. PROCLAIM $297 11 payments
  4. Senza Spinal Cord Stimulation System $140 1 payment
  5. Proclaim Family of SCS IPGs $135 9 payments
  6. ANJESO $67 4 payments
  7. ETERNA $62 2 payments
  8. UBRELVY $56 3 payments
  9. XTAMPZA $26 2 payments
  10. Qutenza $25 1 payment
  11. Other $204 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$17,992

Medicare's payments for the services billed

Medicare patients

58

Average age 76

Services billed

247

37 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 40%
Diabetes 31%
Depression 24%
Atrial fibrillation 21%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

61 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record